<span lang="EN-US" style="font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: 新細明體; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA;">OBIGEN Pharma&rsquo;s OBI-858 is approved by Saudi Authority for Intellectual Property (SAIP) on 18th February 2024. No.521430958 with &ldquo;the title of invention as BOTULINUM TOXIN TYPE A COMPLEX, AND FORMULATION THEREOF AND USAGE METHOD THEREFOR&rdquo;, authorization notice as the below.
<img src="/uploads/%E6%8A%95%E8%B3%87%E4%BA%BA%E5%B0%88%E5%8D%80_%E9%87%8D%E5%A4%A7%E5%85%AC%E5%91%8A/240219_%E6%B2%99%E7%89%B9%E7%9F%A5%E8%AD%98%E7%94%A2%E6%AC%8A%E5%B1%80SAIP%20%E5%B0%88%E5%88%A9%E6%8E%88%E6%AC%8A%E9%80%9A%E7%9F%A5%E6%9B%B8__521430958%20NOA_page-0001.jpg" alt="240219_沙特知識產權局SAIP 專利授權通知書__521430958 NOA_page-0001.jpg" width="1241" height="1754" />
<img src="/uploads/%E6%8A%95%E8%B3%87%E4%BA%BA%E5%B0%88%E5%8D%80_%E9%87%8D%E5%A4%A7%E5%85%AC%E5%91%8A/240219_%E6%B2%99%E7%89%B9%E7%9F%A5%E8%AD%98%E7%94%A2%E6%AC%8A%E5%B1%80SAIP%20%E5%B0%88%E5%88%A9%E6%8E%88%E6%AC%8A%E9%80%9A%E7%9F%A5%E6%9B%B8__521430958%20NOA.pdf" alt="240219_沙特知識產權局SAIP 專利授權通知書__521430958 NOA.pdf" />

OBI-858 Approved by Saudi Authority for Intellectual Property (SAIP), No.521430958